Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Compare index funds with the lowest expense ratios for retirement in 2024 to minimize fees while pursuing solid returns. Find your top pick today.
27,341 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Policy headwinds aren’t the end of the story for solar investors. This guide explains how AI-driven demand, select co...
Arm Holdings trades around $347 as investors weigh AI-driven demand and data-center opportunities. Analysts see a pat...
An executive stock sale can signal many things. This article breaks down the numbers, the reporting rules, and practi...
A sharp look at how Rivian Automotive and Tesla earn money, where their revenue comes from, and what the trends mean ...
Tariffs and policy shifts can erode the gains from tax cuts for households across the income spectrum. This guide bre...
Regulators are examining capital rules that could allow banks to take a bigger share of mortgage lending. Banks say c...
A UC Berkeley analysis tracking households through 2025 finds relocating out of California reduces monthly housing bi...
Coca-Cola beat first-quarter 2026 expectations, raised guidance, and signaled margin improvement from an Africa dives...
Goldman Sachs marks Nvidia and Micron as the leading AI winners ahead of the upcoming earnings season, triggering fre...
Investors are eyeing lululemon (lulu) 2026 earnings to gauge growth momentum and margins. This guide breaks down what...
June 2026 shifts spotlight to Tesla and BYD as margin rebound meets policy tailwinds. Here’s the latest data and what...